CATX实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (29 Jun 2024 @ 04:00):
Our systems believe the stock currently is overvalued by -1.24% compare to its pairs and should correct downwards.

Stats
今日成交量	7.95M
平均成交量	749 104
市值	672.28M
EPS	$-0.0369 ( Q1 \| 2023-09-30 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-5.86 (Sector) 49.64 (Industry) 37.79
ATR14	$0.0480 (0.49%)

ABT -0.71%

ALUR -23.26%

AORT 3.22%

AVNS 1.63%

BFLY -3.33%

BFLY-WT 4.91%

BIO 0.41%

BIO-B 0.00%

BSX 0.01%

BSX-PA 2.37%

CATX 1.01%

CNMD 2.70%

CRY 1.42%

EW -1.04%

FNA 2.86%

GKOS 0.83%

GMED -0.52%

INSP -1.11%

ITGR 1.10%

MDT 0.10%

NVRO 0.72%

OWLT 6.46%

PEN 2.90%

PHG -1.87%

RBOT -15.78%

SNN 0.12%

SONX 0.00%

STE 1.43%

SYK 0.15%

VAPO -1.87%

ZBH 0.14%

Insider Trading

Date	Person	Action	Amount	type
2024-06-20	Williamson Robert F Iii	Buy	23 000	Stock option (right to buy)
2024-06-20	Morich Frank	Buy	23 000	Stock option (right to buy)
2024-06-20	Woods Lori A	Buy	23 000	Stock option (right to buy)
2024-06-20	Henson Heidi	Buy	23 000	Stock option (right to buy)
2024-06-20	Spoor Johan M.	Buy	500 000	Stock option (right to buy)

INSIDER POWER
99.90
Last 36 transactions
Buy: 62 148 790 \| Sell: 30 000

相关性 (AI algo v.1.1b): Overvalued: -1.24% $9.98 paired level. (算法实时跟踪最相关股票的变化并提供即时更新)

音量相关性

長: 0.33 (neutral)

短: 0.02 (neutral)

Signal:(51.936) Neutral

Perspective Therapeutics, 相关性

10 最正相关
KLG	0.836
GAQ	0.823
ECCC	0.819
SBXC	0.819

10 最负相关
AIU	-0.865
CCG	-0.832
BBAI-WT	-0.828
QBTS	-0.82
GETR	-0.807
RTO	-0.806

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Perspective Therapeutics, 相关性 - 货币/商品

0.15
( neutral )

0.11
( neutral )

0.00
( neutral )

-0.35
( neutral )

0.00
( neutral )

-0.31
( neutral )

Perspective Therapeutics, 财务报表

Annual	2022
营收:	$7.10M
毛利润:	$1.63M (23.00 %)
EPS:	$-0.100

FY	2022
营收:	$7.10M
毛利润:	$1.63M (23.00 %)
EPS:	$-0.100

FY	2022
营收:	$10.80M
毛利润:	$4.62M (42.76 %)
EPS:	$-0.0504

Financial Reports:

No articles found.

Perspective Therapeutics, Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Perspective Therapeutics,

Perspective Therapeutics, Inc., together with its subsidiaries, develops, manufactures, sells, and markets isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. The company was formerly known as Isoray, Inc. and changed its name to Perspective Therapeutics, Inc. in February 2022. Perspective Therapeutics, Inc. was founded in 1998 and is based in Richland, Washington.